Latest / Pharmacy Podcast Network / NCPA 2024 Annual Convention Coverage | Part One
Transcript
- 0:05Speaker 1: You are listening to the global network of podcasters dedicated
- 0:08Speaker 1: to the pharmacy profession Welcome to the Pharmacy Podcast Network.
- 0:28Speaker 2: Welcome to the Pharmacy Podcast networks exclusive coverage of the
- 0:32Speaker 2: National Community Pharmacists Association and CPA twenty twenty four annual convention,
- 0:38Speaker 2: recording live from Columbus, Ohio. Known as the super Bowl
- 0:42Speaker 2: of Independent Community pharmacy, this event is the only industry
- 0:46Speaker 2: conference designed specifically for the needs of the community pharmacy professionals.
- 0:51Speaker 2: In this special three part podcast series, the Pharmacy Podcast
- 0:55Speaker 2: Network dives deep into the event's highlights, bringing you firsthand
- 0:58Speaker 2: insights from the industry leaders, innovators, and attendees who are
- 1:02Speaker 2: shaping the future of community pharmacy. From groundbreaking ideas to
- 1:06Speaker 2: actionable strategies, We've got it all covered.
- 1:16Speaker 3: Hey Steve, Hey Thomas. Good to see it.
- 1:18Speaker 4: So I'm Tom the Poultana with real Value. I know
- 1:22Speaker 4: Steve a long time as a vendor of ours, and
- 1:26Speaker 4: I think yesterday's is an example. You and I had
- 1:30Speaker 4: a real life conversation we did in a booth and
- 1:34Speaker 4: we were talking about how you know, we bother you
- 1:38Speaker 4: and Joe Hodge on your team to get product because
- 1:42Speaker 4: Julida cane five percent patch has been in short supply
- 1:45Speaker 4: of course the whole country.
- 1:47Speaker 3: Yeah, you know, we're facing a unique dynamic in the
- 1:49Speaker 3: marketplace now where drug shortage is becoming bigger and bigger,
- 1:53Speaker 3: and there's a number of factors for that. Maybe it's
- 1:55Speaker 3: not probably the point here to go through all those
- 1:57Speaker 3: specific factors, you know, because it could be anything from
- 2:00Speaker 3: lack of API to margins manufacturers are making now that
- 2:05Speaker 3: number of them exit the market because it's not profitable
- 2:08Speaker 3: to them anymore because of how the system works. But
- 2:11Speaker 3: most importantly, it's our job to do that. Our job
- 2:16Speaker 3: is to help you get product to the patient and
- 2:19Speaker 3: to your downstream customers. And so in the case of
- 2:22Speaker 3: light kin patch, it is a unique challenge because we've
- 2:25Speaker 3: had three manufacturers exit the market just in the last
- 2:30Speaker 3: probably twelve months. Other manufacturers that make that product have
- 2:34Speaker 3: already stated openly to yourself probably and to other customers
- 2:40Speaker 3: that we're not making more. And ural happens to be
- 2:43Speaker 3: the one customer or one supplier that we are trying
- 2:46Speaker 3: to actually increase our supply. So I will tell you
- 2:50Speaker 3: that all the customers of this fine organization, they work
- 2:54Speaker 3: very hard to get as much product from us, and
- 2:56Speaker 3: we try to do the best to give as much
- 2:57Speaker 3: product back.
- 2:58Speaker 5: And that's where I want to give you credit where
- 3:00Speaker 5: you can.
- 3:00Speaker 4: Just respond to the mammoths, the Big three or some
- 3:05Speaker 4: other large customers. But but you are you know, you
- 3:07Speaker 4: know that we all have customers that rely on us
- 3:10Speaker 4: getting in the products because they rely on us.
- 3:12Speaker 5: So you have been fair and.
- 3:13Speaker 4: How you try to take a product that's short and
- 3:17Speaker 4: satisfy all of your customer base and you know you
- 3:20Speaker 4: have come through for us, and we do.
- 3:21Speaker 3: Appreciate, well, I appreciate that comment. And quite frankly, we
- 3:24Speaker 3: know how the industry works, and we know I don't
- 3:26Speaker 3: think anybody's in the industry doesn't know the term the
- 3:28Speaker 3: Big three and obviously they're part of the system, but
- 3:32Speaker 3: commre but to me personally, especially as a young company
- 3:36Speaker 3: and a smaller company, you know, our philosophy has always been,
- 3:40Speaker 3: especially on the generic side of the strategies always used
- 3:42Speaker 3: to be the most products win, right, the most marbles win.
- 3:45Speaker 3: But really what we're talking about as the evolution is
- 3:48Speaker 3: not growing. It's about having the right marbles. And you know,
- 3:51Speaker 3: products like lydocine becomes a very important product to you
- 3:54Speaker 3: and to your downstream customers. So that's what we want
- 3:58Speaker 3: to try to do. We want to make as much
- 4:00Speaker 3: of an even playing field and try to bring product
- 4:04Speaker 3: to all our customers outside the Big three, because we
- 4:08Speaker 3: know how important you guys play. You guys service different customers.
- 4:10Speaker 3: You have different value propositions that you bring to your customers,
- 4:14Speaker 3: and that translates back to us too sometimes. So that's
- 4:16Speaker 3: really what's important. So I know what other thought topics
- 4:20Speaker 3: did we think we have that are burning your challenges?
- 4:24Speaker 3: Maybe I can respond to how as a manufacturer we
- 4:27Speaker 3: want to try to address those.
- 4:28Speaker 4: Now what we're focusing on right now is and what
- 4:32Speaker 4: I like to see is in the past, these all
- 4:34Speaker 4: the shows. In the past, you would see the Big three,
- 4:37Speaker 4: the giant boosts, and you look around and it's there here.
- 4:40Speaker 4: But we have several regional, national secondary wholesalers also having
- 4:46Speaker 4: this big presency.
- 4:47Speaker 5: You could see how the market is changing.
- 4:50Speaker 3: Yeah, and I think ultimately it's going to change. I
- 4:52Speaker 3: think you guys are actually well positioned to start where
- 4:56Speaker 3: the evolution is going to go because at some point
- 4:58Speaker 3: the way the business flows now right it can't be sustainable.
- 5:05Speaker 3: There's going to be changes. There's going to be a
- 5:07Speaker 3: tipping point in this industry. And as a manufacturer, if
- 5:11Speaker 3: we are looking ahead, I always tell our team our
- 5:13Speaker 3: job is to get ahead of the curve. You know,
- 5:16Speaker 3: we got to be doing what we need to do
- 5:17Speaker 3: today to make our business metrics, but we've got to
- 5:20Speaker 3: be thinking about what's happening six months, twelve months, twenty
- 5:22Speaker 3: four months ahead, and there will be changed. I mean,
- 5:25Speaker 3: we cannot sustain in this system that eighty plus percent
- 5:30Speaker 3: or whatever the number is now of all drug flow
- 5:32Speaker 3: is running through the Big Three. Again, they are partners
- 5:36Speaker 3: and we will work with them, but we also need
- 5:38Speaker 3: to understand that that customer dynamic and that partnership dynamic
- 5:42Speaker 3: will continue to change just in terms of how we
- 5:45Speaker 3: deliver it down to the end user. And that's why
- 5:47Speaker 3: you guys are so important, and that's why we want
- 5:50Speaker 3: to make sure that all our potential customers direct customers,
- 5:55Speaker 3: we can have a meaningful and successful relationship. And if
- 5:59Speaker 3: we can do that, then everybody wins the most importantly,
- 6:02Speaker 3: the patient wins.
- 6:03Speaker 6: Night excellent, Hey, listeners, stay tuned for more coming from
- 6:06Speaker 6: the NCPA twenty twenty four post show coverage. We're here
- 6:10Speaker 6: live at the Real Value RX Booth.
- 6:13Speaker 7: There's more to come. Stay tuned.
- 6:20Speaker 6: Hey, I met Eric Collins from Retail My Meds and
- 6:24Speaker 6: we did a special podcast episode in series so much.
- 6:28Speaker 6: Appreciate you bringing us an enlightenment to the platform and
- 6:30Speaker 6: what you're doing for community pharmacy. Welcome to the NCPA
- 6:34Speaker 6: twenty twenty four.
- 6:35Speaker 8: Thank you very much for having me.
- 6:37Speaker 6: All right, and we are here at the Real Value Booth. Tom,
- 6:40Speaker 6: It's so good to be part of your team. It
- 6:42Speaker 6: just got done talking with Stephanie. There's a special relationship
- 6:46Speaker 6: that Erica and Real Value has. I want to go
- 6:49Speaker 6: through kind of like some of the issues with shipping
- 6:52Speaker 6: and how you guys have actually worked together and kind
- 6:55Speaker 6: of that story.
- 6:56Speaker 7: I think that's a special story and just turn it
- 6:58Speaker 7: over to you.
- 6:58Speaker 5: I appreciate Beth.
- 6:59Speaker 8: Yeah, absolutely, Hey Tom, So Yeah, we've been using Real
- 7:03Speaker 8: Value products in our pharmacy for several years now and
- 7:08Speaker 8: we've you know, we've grown to have a very good
- 7:10Speaker 8: relationship with your company, and we were excited to learn
- 7:14Speaker 8: a little bit about the growth that you're having because
- 7:17Speaker 8: you're so popular and you know, a lot of pharmacies
- 7:20Speaker 8: are really catching on to a lot of the great
- 7:22Speaker 8: products that you offer. O.
- 7:24Speaker 5: Thanks.
- 7:24Speaker 4: So I know that our performance the last six months
- 7:28Speaker 4: or so has been lacking and that is now officially
- 7:32Speaker 4: going to change if I want to, I just want
- 7:35Speaker 4: to step back.
- 7:35Speaker 5: A few years ago.
- 7:36Speaker 4: We made a decision as a company to really become
- 7:39Speaker 4: data and driven, and we have a team of eight
- 7:43Speaker 4: to ten data scientists. So it helped us in procuring
- 7:46Speaker 4: the right products, making sure warehousing it would make sense,
- 7:48Speaker 4: getting it.
- 7:49Speaker 5: At the best cost.
- 7:50Speaker 4: And then also we look at the market the reimbursement
- 7:53Speaker 4: of different products, how we can help you guys make
- 7:55Speaker 4: sure you're carrying the right product mix to keep your
- 7:57Speaker 4: business afloat and hopefully you know I have your profit
- 8:00Speaker 4: of So we did that model work for us to
- 8:04Speaker 4: the point where we grow grew so fast the last
- 8:07Speaker 4: several years, one of the fastest growing wholesales, if not
- 8:09Speaker 4: the fastest that our manual warehouse process. It just overgrew
- 8:14Speaker 4: and we would struggle, particularly on like a Monday could
- 8:16Speaker 4: get all your weekend orders. So we'd struggled, and our CEO,
- 8:21Speaker 4: Fred Peta, made the decision to just invest a significant
- 8:26Speaker 4: amount of money to bring full automation robotics into our facility.
- 8:31Speaker 4: So as we will continue to grow and doing all
- 8:35Speaker 4: the work to begin that transition. We still had some
- 8:38Speaker 4: missteps on shipping, so everyone would get their order sometimes
- 8:41Speaker 4: and not the next day, but they would get it
- 8:43Speaker 4: in two days. But that still was disruptive because they
- 8:46Speaker 4: expected next day and we get that and moved that part.
- 8:48Speaker 4: We do apologize for. But what really compounded, what made
- 8:52Speaker 4: it the perfect storm, was when we made the announcement, Okay,
- 8:55Speaker 4: we're going to close a couple of days and we're
- 8:57Speaker 4: going to put our robots online. So they all took
- 9:00Speaker 4: that as well, then you're going to everything's going to
- 9:02Speaker 4: arrive next day one hundred percent. And forgetting that with
- 9:05Speaker 4: any transition, no matter why, whether it's SAP conversions or
- 9:10Speaker 4: robotic conversions like we had, it has to be bumps.
- 9:13Speaker 4: And so when we stumbled out, it kind of was
- 9:15Speaker 4: the perfect storm because they were like, we thought everything
- 9:18Speaker 4: was fixed. The robot see and everything's perfect, and you know,
- 9:21Speaker 4: we just had to get through the transition.
- 9:23Speaker 5: We have passed that. Now we're getting everything out on time.
- 9:25Speaker 4: Now we're built for absolute growth. You're not going to
- 9:28Speaker 4: have those issues with us anymore. We're going to be
- 9:31Speaker 4: able to carry much more products. We have five thousand
- 9:34Speaker 4: Now we're going to hope to get that to seven
- 9:36Speaker 4: eight thousand and nine. And to the cost of this
- 9:37Speaker 4: increased capacity, we're going to try to extend our shipping times.
- 9:41Speaker 4: Right now our cut off a six thirty central. We're
- 9:44Speaker 4: going to try to push that to seven, seven thirty
- 9:46Speaker 4: or even eight. So those are the opportunities. Now we're
- 9:50Speaker 4: going to be a reliable source for you going forward
- 9:54Speaker 4: and you get all the all the expertise that our
- 9:56Speaker 4: data drives and helps you make the my product decisions.
- 10:00Speaker 8: I think that's a wonderful news. And you know, I
- 10:02Speaker 8: appreciate your transparency with the issues that you've had, you know,
- 10:05Speaker 8: with your growth challenges. But it's you know, it's it's
- 10:09Speaker 8: it's a short term situation to a great solution, not
- 10:14Speaker 8: only for you as a company and the growth that
- 10:17Speaker 8: you're trying to achieve, but also for the owners and
- 10:21Speaker 8: the pharmacy decision makers. So I'm I'm excited for that. Yes,
- 10:25Speaker 8: we were affected by that hiccup a little bit, but
- 10:28Speaker 8: it was not it was it was not something that
- 10:31Speaker 8: we couldn't deal with and move forward on. So but
- 10:35Speaker 8: we're perfectly fine. We were happy with that We're excited
- 10:38Speaker 8: for the continued relationship and to see what's next.
- 10:41Speaker 4: Yeah, it was interesting to find that nearly ninety to
- 10:45Speaker 4: ninety five.
- 10:45Speaker 5: Percent of our customers supporting us.
- 10:47Speaker 4: They might have been, you know, gave us a message two,
- 10:50Speaker 4: but they were supporting. And you had the five percent that, well,
- 10:53Speaker 4: you know, you ship me a day late. I want
- 10:55Speaker 4: everything free for the rest of our lives, and you
- 10:56Speaker 4: know you get that. But no, in general, people were understanding.
- 11:01Speaker 5: So I will give people credit for that.
- 11:03Speaker 4: But I mean I presented to about sixty five manufacturers last.
- 11:06Speaker 5: Week and I made a comment that.
- 11:09Speaker 4: What doesn't kill you makes you stronger, and I said,
- 11:12Speaker 4: we are now the strongest company in America.
- 11:15Speaker 5: That's how I feel. It did make us stronger.
- 11:18Speaker 8: I think that's that's a great Those are great words
- 11:20Speaker 8: to live by. Absolutely, and I think that all of
- 11:23Speaker 8: us in the industry at this time are are more
- 11:26Speaker 8: than willing to provide a little grace in these types
- 11:28Speaker 8: of situations because we're all going through our own struggles.
- 11:31Speaker 5: So I appreciate that.
- 11:33Speaker 6: Yeah, business, the business relationships that I've experienced over the years,
- 11:37Speaker 6: where I've had either a vendor, a partner, or someone
- 11:41Speaker 6: that I'm serving one of my own clients where we've
- 11:44Speaker 6: experienced some kind of mishap or mistake or something that
- 11:47Speaker 6: we got through and we ended up redefining something else
- 11:51Speaker 6: of communication or process. It strengthened me, and so I
- 11:55Speaker 6: think this is a testimony of strengthening not only not
- 12:00Speaker 6: only pharmacy in general, but community pharmacy relationships where you're
- 12:05Speaker 6: not going to be perfect with your patients one hundred
- 12:08Speaker 6: percent of the time and real value and a community
- 12:11Speaker 6: pharmacy out there that's not going to be perfect one
- 12:14Speaker 6: percent of the time. What we're going to do is
- 12:16Speaker 6: we're going to commit to work with each other for
- 12:18Speaker 6: each other's.
- 12:19Speaker 7: Combined success because we.
- 12:21Speaker 6: Kind of have to with everything that's going on right
- 12:23Speaker 6: now in pharmacy care and community pharmacy specifically, and we
- 12:26Speaker 6: have to.
- 12:27Speaker 4: Work together because we share common I'm not going to
- 12:29Speaker 4: use word enemies, but you know, we're trying to help
- 12:33Speaker 4: retail independent pharmacies in creating it probably stay in business, true,
- 12:37Speaker 4: and there's a lot of forces out there without naming
- 12:39Speaker 4: names that really get in our way of that.
- 12:41Speaker 5: So yeah, we'd have to work together absolutely.
- 12:44Speaker 6: Erica, this has been really special for you to join
- 12:46Speaker 6: us on the NCPA twenty twenty four post show review
- 12:50Speaker 6: here at the Real Value our ex boot.
- 12:52Speaker 5: Thank you, thank you so much, Thanks ch thank you.
- 13:00Speaker 6: One of the themes at the NCPA twenty twenty four
- 13:04Speaker 6: this year that has been consistent is how pharmacy care
- 13:08Speaker 6: is changing, how community pharmacy is changing. If we don't
- 13:12Speaker 6: have organizations that we can rely on to not only
- 13:15Speaker 6: reflect but accept that change and then drive independent community
- 13:20Speaker 6: pharmacies towards success, it's hard to get any kind of momentum.
- 13:24Speaker 6: And one of those organizations that are constantly thinking of
- 13:27Speaker 6: the future is Real Value our X. And I'm sitting
- 13:31Speaker 6: here with Stephanie Zimmerman. You're the lead of business development,
- 13:34Speaker 6: but you're also the lead of strategy. Talk to us
- 13:37Speaker 6: about what you've experienced here at NCPA and how Real
- 13:41Speaker 6: Value is picking up the pace and knowing that twenty
- 13:44Speaker 6: twenty five is going to be a much different but
- 13:46Speaker 6: also a more profitable year.
- 13:48Speaker 9: Yeah, thank you, Todd. So I think you know the
- 13:50Speaker 9: theme that I'm seeing. The common denominator is profit obviously,
- 13:54Speaker 9: and you know everyone's tired of, you know, having to
- 13:59Speaker 9: fill those those prescriptions that are lost leaders, they're losing
- 14:03Speaker 9: money on them and you know, how do we make
- 14:07Speaker 9: a profit on on some of these medications. We have
- 14:11Speaker 9: to fill you know, certain medications for for for I
- 14:15Speaker 9: mean for our customers. We have to feel those certain
- 14:17Speaker 9: medifications for them. But what we can also do is,
- 14:22Speaker 9: you know, we have some higher AWP products that is
- 14:26Speaker 9: beneficial and good for the patient. So we we offer
- 14:31Speaker 9: a lot of products that you may or may not
- 14:33Speaker 9: know about. So we want to make sure that you
- 14:35Speaker 9: have a UH salesperson that can actually share with you, you know,
- 14:40Speaker 9: directly some of these new products that we're having or
- 14:43Speaker 9: were carrying, and then it's going really really well in
- 14:46Speaker 9: their states. And again they're beneficial for the patient. We
- 14:50Speaker 9: make sure of that. And you know, it could be dosing,
- 14:53Speaker 9: it could be you know, any of those. Yeah, mainly
- 14:57Speaker 9: mainly dosing and mainly getting the get into the right hands.
- 15:01Speaker 9: We also work with physicians, you know, and I think
- 15:03Speaker 9: that's a big deal. And we also the biggest thing
- 15:06Speaker 9: to me is marketing. I hear all the time that
- 15:08Speaker 9: pharmacists cannot do marketing, and they can't you know, it's like, oh.
- 15:12Speaker 3: I don't have time, I don't have time.
- 15:14Speaker 7: Well, Real Value.
- 15:15Speaker 9: Actually has marketing material that we can actually give to
- 15:17Speaker 9: you that give you know, you give it to the
- 15:19Speaker 9: pharmacist and then they therefore pass it to the positions.
- 15:25Speaker 9: So it works. It works super easy. If you have
- 15:28Speaker 9: an account with us, you can easily get into our
- 15:31Speaker 9: portal and then you have for marketing material and it
- 15:34Speaker 9: makes like you don't have to do any.
- 15:36Speaker 7: Of the work.
- 15:37Speaker 9: We have all of that done them.
- 15:39Speaker 6: Something else that listeners might not realize about real value
- 15:43Speaker 6: is your entire background. Just like my entire background in
- 15:46Speaker 6: pharmacy has always been around business development. So what's a
- 15:50Speaker 6: little bit edgier than just being in marketing. You and
- 15:54Speaker 6: I have taken communications and messaging and developed relationships with
- 15:58Speaker 6: organizations that turn into business. And something that you do
- 16:02Speaker 6: for your clients and for owners to really start thinking
- 16:06Speaker 6: is thinking a little differently and being more of a
- 16:09Speaker 6: coach because of your background in coaching community pharmacy owners.
- 16:13Speaker 6: How do you take a product, how do you take
- 16:15Speaker 6: an event? How do you take something that's happening in
- 16:17Speaker 6: your geographic area and capitalizing on it based on what's
- 16:21Speaker 6: happening in the news, based on what people are seeing
- 16:24Speaker 6: on Facebook.
- 16:25Speaker 7: And then we take a product that.
- 16:26Speaker 6: Is needed anyway, and you just leverage it just to
- 16:29Speaker 6: get it out there to the community.
- 16:31Speaker 9: Right right, So you know, you hear about GLP ones.
- 16:35Speaker 9: You know, what I like to think about is the
- 16:37Speaker 9: adjunct therapy that goes along with it. So you know, yeah,
- 16:40Speaker 9: you might be losing a profit, you might. You know,
- 16:43Speaker 9: some people are very successful, some people are not, but
- 16:46Speaker 9: they want to carry it and they're very interested and
- 16:48Speaker 9: that's what the community is interested. And so with that said,
- 16:53Speaker 9: it's like, how can we be profitable with that? And
- 16:55Speaker 9: I would say add on to that, run those run
- 16:58Speaker 9: those other reports of on danceatron, you know, laculos, all
- 17:03Speaker 9: of the things that is needed because of the side
- 17:06Speaker 9: effects with gop one.
- 17:09Speaker 1: So we if we can look at it in.
- 17:11Speaker 9: That sense, we could actually be very very profitable, you know.
- 17:15Speaker 9: So I always yeah, it's the coaching and coming up
- 17:18Speaker 9: with solutions to problems. That's the biggest thing for me.
- 17:21Speaker 9: Is because a lot of times we just don't think.
- 17:23Speaker 9: We just need an army to think about some of
- 17:25Speaker 9: the things that we just don't know about.
- 17:28Speaker 6: So there's so much stress on our owners right now
- 17:32Speaker 6: that sometimes pigeonhole and having too much focus on one thing,
- 17:38Speaker 6: you are giving these owners just a little bit of
- 17:41Speaker 6: extra information to think things a little bit differently from
- 17:43Speaker 6: a different angle, and then the lights start going off,
- 17:46Speaker 6: and then the trust that they already have with their community,
- 17:49Speaker 6: it's exemplified and leveraged because now you can talk about
- 17:52Speaker 6: a patient about a specific product.
- 17:54Speaker 7: Or a change or whatever it is.
- 17:55Speaker 6: So that this is why this is important for real
- 17:58Speaker 6: value in our list as well as the pharmacy owners
- 18:01Speaker 6: out there is just get together for a strategy, opportunity,
- 18:05Speaker 6: a program. Share with Stephanie kind of what you're doing,
- 18:07Speaker 6: what you're seeing happening in your markets.
- 18:09Speaker 7: And that might be.
- 18:10Speaker 6: Different Pittsburg markets, different than Orlando, or different than Idaho,
- 18:13Speaker 6: or different than somewhere in California. But you have so
- 18:16Speaker 6: much coverage everywhere that I think you can give the client.
- 18:20Speaker 6: You can give the pharmacy owner a perspective specific to
- 18:22Speaker 6: the markets that they're in.
- 18:24Speaker 9: Yes, absolutely, yeah, And what are your obstacles, Let's figure
- 18:28Speaker 9: them out, figure them out together. And then, like you said,
- 18:31Speaker 9: they're already filling most of these medications, so you know,
- 18:35Speaker 9: we can figure out like what is profitable in the
- 18:38Speaker 9: areas working with the physicians in the area. You know,
- 18:41Speaker 9: give me your top five, I would say, run your reports.
- 18:43Speaker 9: I need a T shirt that says run your reports,
- 18:45Speaker 9: because I have said that so many times. Run your
- 18:47Speaker 9: reports on your top five medications. Now let's figure out
- 18:51Speaker 9: what can either go along with them because of the
- 18:53Speaker 9: side effects, or what could we do to either work
- 18:57Speaker 9: with your physician to get you a profitable medication. So
- 19:01Speaker 9: there's a lot of ways we can do that and
- 19:03Speaker 9: stay alive because, as we know, we have to have
- 19:07Speaker 9: to ride.
- 19:07Speaker 6: Yeah, we have to thrive. Stephanie Zimmerman here at OURX value,
- 19:13Speaker 6: RX value, Real Value, our ex It's been exciting to
- 19:16Speaker 6: work with you and your team here at NCPA twenty
- 19:19Speaker 6: twenty four. I'm excited about the future of pharmacy in
- 19:21Speaker 6: twenty twenty five. We can't wait to hear more from
- 19:24Speaker 6: you in the new year as well.
- 19:25Speaker 9: Thank you, Tood, thanks for being with us today.
- 19:27Speaker 6: Absolutely a big part of the future of community pharmacy
- 19:38Speaker 6: is being able to build cash based systems that have
- 19:43Speaker 6: value that the community needs. And the element that I
- 19:47Speaker 6: know is an issue is the lack of nursing homes
- 19:51Speaker 6: and the lack of assistant the living centers.
- 19:53Speaker 7: But people don't want to go to those places. People
- 19:56Speaker 7: want to stay in their home.
- 19:58Speaker 6: Talk to me about Happier at Home, Introduce yourself to
- 20:01Speaker 6: the NCPA twenty twenty four listeners and let them know
- 20:05Speaker 6: what you do in community pharmacy.
- 20:08Speaker 7: Sure.
- 20:08Speaker 10: So, my name is Dana Porter. I'm here with my
- 20:10Speaker 10: husband Toby Porter.
- 20:12Speaker 3: Good morning.
- 20:14Speaker 10: We own a group of community pharmacies out of southern
- 20:18Speaker 10: California as well as a Happier at Home franchise, and
- 20:22Speaker 10: we launched the Happier at Home franchise, purchased it about
- 20:26Speaker 10: a year and a half ago, and have found going
- 20:29Speaker 10: into a cash base model has really helped the pharmacy
- 20:32Speaker 10: has helped us grow our patient base in the home
- 20:36Speaker 10: care because there is a huge need in our community.
- 20:40Speaker 6: Toby, go through us from your perspective of how your
- 20:44Speaker 6: community was impacted by a home care organization that understood
- 20:48Speaker 6: how pharmacy is connected to that.
- 20:51Speaker 11: Sure, I think one of the things that community pharmacy
- 20:56Speaker 11: has done really well over its its long tenure in
- 21:01Speaker 11: the community is recognizing the needs of its customers and
- 21:05Speaker 11: it and its place in the community. Community pharmacists are
- 21:10Speaker 11: so flexible and need to change constantly that when we
- 21:15Speaker 11: see a need, we respond immediately, and that's kind of
- 21:19Speaker 11: where Happier at Home came about. There is such a need,
- 21:23Speaker 11: like you mentioned, and taking care of our customers is
- 21:26Speaker 11: not just within the pharmacy four walls anymore, that we
- 21:30Speaker 11: need to go out into the community and help these
- 21:33Speaker 11: folks stay healthy in their homes.
- 21:37Speaker 6: I also think of the element of revenue and how
- 21:40Speaker 6: we started off the conversation talking about a cash based system.
- 21:44Speaker 6: Talk to me about the potential based on how you've
- 21:49Speaker 6: seen things grow so far. Add me twenty five more homes,
- 21:53Speaker 6: Add me one hundred more homes. Add in two hundred
- 21:56Speaker 6: homes that become part of your Happier Home franchise. Give
- 22:01Speaker 6: our listeners a little aspect of kind of like revenues
- 22:04Speaker 6: that are that are potentially out there.
- 22:08Speaker 10: Well, I think we've been in business a year and
- 22:10Speaker 10: a half and we've grown about four hundred percent.
- 22:13Speaker 7: Oh my god, we need that's credit.
- 22:15Speaker 10: We kind of add on clients every week, clients that
- 22:17Speaker 10: call us through you know, pharmacy relationships, through our relationship
- 22:21Speaker 10: with doctors in the community, and we just keep growing.
- 22:24Speaker 10: But it's sort of a passive income type of situation
- 22:27Speaker 10: because once you've onboarded a client, you've done a good
- 22:30Speaker 10: job placing a caregiver and they're reliable, They go to
- 22:33Speaker 10: work and you build the shifts and the patients are happy.
- 22:35Speaker 10: There is some maintenance that's involved in that, But as
- 22:38Speaker 10: we continue to grow, it isn't where the growth from.
- 22:41Speaker 10: You know, we count hours right from two hundred hours
- 22:46Speaker 10: to four hundred hours isn't doubling the work. It's just
- 22:49Speaker 10: onboarding patients and getting them set and making sure you're
- 22:51Speaker 10: doing a good job. So as we continue to grow,
- 22:54Speaker 10: we sort of see that we could grow from four
- 22:56Speaker 10: hundred hours to six hundred hours and be continuing to
- 22:59Speaker 10: do the same thing, not really working that much more,
- 23:02Speaker 10: but having this passive income coming to us.
- 23:06Speaker 6: Toby, what about NCPA, How have you seen the value
- 23:10Speaker 6: of coming to this conference and the education, the networking.
- 23:15Speaker 11: Talk to us about your experience here in Columbus. Well,
- 23:18Speaker 11: what's great about NCPA and many of the other shows
- 23:24Speaker 11: that you can attend within the pharmacy community is seeing
- 23:28Speaker 11: and being with all of your colleagues that you may
- 23:31Speaker 11: only see once or twice a year at various events,
- 23:34Speaker 11: seeing what their challenges are, what their successes are, collaborating
- 23:40Speaker 11: you might not have the same issues that you're they're
- 23:44Speaker 11: discussing in open form sessions yet but perhaps you will soon.
- 23:49Speaker 11: So it's nice to get ahead of those situations seeing
- 23:53Speaker 11: all the vendors and the new product that's out and
- 23:55Speaker 11: the items that you may or may not be coming
- 23:59Speaker 11: in contact with soon and have that demand in your store.
- 24:02Speaker 11: So it's hugely beneficial, kind of get your your juices
- 24:06Speaker 11: going again and get you a little bit more energized,
- 24:10Speaker 11: take some ideas back home and move forward.
- 24:13Speaker 6: We're big fans of you both and charging and growing
- 24:18Speaker 6: being part of nine to eighty six Degrees Corporation as well,
- 24:21Speaker 6: and what.
- 24:24Speaker 7: Doctor Ty has built.
- 24:26Speaker 6: You're kind of like that supercharged pharmacy of the future
- 24:30Speaker 6: where you're fusing in different ways to survive and thrive,
- 24:33Speaker 6: and it's just awesome to see how you guys are growing.
- 24:36Speaker 6: So you have to be back on a future show
- 24:39Speaker 6: so we can dig in.
- 24:40Speaker 7: Thanks Todd, appreciate you living us.
- 24:42Speaker 10: Yeah, I appreciate you too.
- 24:48Speaker 6: Special time here at NCPA twenty twenty four Mark. It
- 24:52Speaker 6: is so good to be hang out with you here
- 24:54Speaker 6: at the Ural Pharma Booth, Booth number nine zero zero
- 24:58Speaker 6: nine hundred.
- 25:00Speaker 7: Thank for the show, Thank you Todd, and well well
- 25:02Speaker 7: echo your sentiment there It is a fabulous time to
- 25:06Speaker 7: be here at NCPA in Columbus, Ohio. Quite frankly, quite
- 25:10Speaker 7: the place for our conference. Everything's nice and connected, everyone's together.
- 25:14Speaker 7: We don't have to walk seven point four miles to
- 25:16Speaker 7: get to anything. It's all good. Yeah, it's kind of
- 25:19Speaker 7: like taking care of patients in pain. We need to
- 25:21Speaker 7: make it lives easier.
- 25:23Speaker 5: Right.
- 25:24Speaker 6: Hey, we do have another guest here with us, the
- 25:27Speaker 6: CEO of your Roll Pharma, Steven Beckman, one of my
- 25:30Speaker 6: friends from Brownsville, Pennsylvania.
- 25:32Speaker 7: He actually didn't have to fly here either, just like me.
- 25:35Speaker 3: That's right. In fact, I don't think any one of
- 25:37Speaker 3: us drove or off floor. We all drove. So it's
- 25:40Speaker 3: great to be back in Columbus. Actually, this is where
- 25:42Speaker 3: my family's from, so I've got a lot of ties
- 25:45Speaker 3: and spent my youth for many many years coming back
- 25:48Speaker 3: hanging out with my grandparents and work in our family
- 25:50Speaker 3: farm and things like that. So Columbus is a wonderful,
- 25:54Speaker 3: wonderful place, and it's been amazing how much it's grown
- 25:57Speaker 3: in the last couple of years. So it's a great
- 25:59Speaker 3: venue for this conference.
- 26:03Speaker 7: So, Mark, where do we want to start the pain Frontier?
- 26:08Speaker 7: It is vast right. Well, you know, there's a lot
- 26:12Speaker 7: of a lot of folks strolling around NCPA, whether it's
- 26:15Speaker 7: in the exhibit hall or going through all the sessions.
- 26:17Speaker 7: You know, what's the actual uh, what's the hubbub about,
- 26:21Speaker 7: what's the vibe on the street. What have you been
- 26:23Speaker 7: hearing you have you heard anything from people?
- 26:25Speaker 3: Yeah? Well, you know. The first thing is URUND has
- 26:28Speaker 3: been putting a lot of effort to focus in on
- 26:31Speaker 3: the pharmacist channel. We believe that it is as critical
- 26:36Speaker 3: as any other health provider in the system, right physician
- 26:41Speaker 3: or other. And we just we continue to see that
- 26:45Speaker 3: the pharmacist doesn't always get all the information all the
- 26:49Speaker 3: time or as fast, and they should be right there
- 26:51Speaker 3: to the front lines with everybody, or they are at
- 26:52Speaker 3: the front line, so they should have everything. So one
- 26:54Speaker 3: of the most important things that we're really trying to
- 26:57Speaker 3: do as a company is to be at events like
- 26:59Speaker 3: this to continue to talk about our portfolio. And a
- 27:05Speaker 3: big topic obviously about our portfolio is because we have
- 27:07Speaker 3: both the close neck patch and we have lighto kin patch.
- 27:11Speaker 3: Is the is the ongoing evolution and management or change
- 27:16Speaker 3: management and pain which obviously you're a big leader in that.
- 27:19Speaker 3: So what we're hearing a lot about is how do
- 27:21Speaker 3: we continue to adjust to the to managing pain down
- 27:27Speaker 3: to the patient and how do you identify the different options.
- 27:30Speaker 3: I know, when we have spoken in the past, the
- 27:33Speaker 3: big thing that's always stuck with me as you say
- 27:35Speaker 3: we need options. Yep, you know, options are important. That
- 27:38Speaker 3: means different types of products, different types of form, factors
- 27:43Speaker 3: in which those products are delivered in and our case
- 27:45Speaker 3: topical patch. So what are we doing to help facilitate
- 27:51Speaker 3: that conversation? And I think people are still very interested
- 27:54Speaker 3: the question between our ex and OTC. You know, these
- 27:58Speaker 3: are the things that we're hearing and the most important
- 28:00Speaker 3: thing that we want to do is make sure that
- 28:02Speaker 3: we do our part to educate and communicate around those options.
- 28:07Speaker 3: So I think that's what's exciting, and we're glad to be.
- 28:10Speaker 7: Here absolutely And and you know, a couple of those
- 28:12Speaker 7: topics really I think resonate with a lot of folks
- 28:15Speaker 7: that are either here in Columbus or at home on
- 28:18Speaker 7: an exercise bike or wherever in the world you're at
- 28:20Speaker 7: out there as far as the Pharmacy Podcast Network goes,
- 28:23Speaker 7: But you know that the meeting the people where they
- 28:26Speaker 7: are the the you know, there's so many community pharmacy leaders, owners, technicians, pharmacists, marketers,
- 28:34Speaker 7: you name it, that are that are at NCPA, and
- 28:37Speaker 7: what what these folks are talking about is what's pivotal
- 28:41Speaker 7: on what's most important. And you know, to see that
- 28:44Speaker 7: you're here is wonderful and you know, supporting things and
- 28:48Speaker 7: getting these conversations going a little bit further of the
- 28:51Speaker 7: you know, the having a place at the table, being
- 28:53Speaker 7: the room where it happens, the you know, the infamous
- 28:55Speaker 7: Hamilton quote. I guess we'll say, but you know, when
- 28:59Speaker 7: when folks are making those decisions you mentioned, you know,
- 29:02Speaker 7: I'm all about having the options there. It's really incredibly
- 29:06Speaker 7: important for all clinicians, whether it's prescribers, dispensers, whoever the
- 29:11Speaker 7: heck is, in whatever clinic to know and remember in
- 29:14Speaker 7: those micro moments what's available. You know, you know in
- 29:18Speaker 7: our not even our country, heck, our hemisphere probably and
- 29:22Speaker 7: our continent, topicals are over it's not even that they're overlooked.
- 29:26Speaker 7: It's like this forgotten frontier of the Oh, we we'll
- 29:29Speaker 7: get to that if we need to, you know, step
- 29:31Speaker 7: seven out of eighteen or something. And it's like, no, no, no,
- 29:36Speaker 7: that should be right there at the forefront. And that's
- 29:40Speaker 7: you know, conversations I've been overhearing. What do we do
- 29:42Speaker 7: with pay managin. Yes, we need the options, but we
- 29:45Speaker 7: need to be aware of what's already readily available too.
- 29:48Speaker 3: Well, your point's really well taken because you know, we
- 29:51Speaker 3: can do all kinds of things when as a manufacturer,
- 29:54Speaker 3: we can do qualitative and quantitative market research and we
- 29:58Speaker 3: can pull people in, but those are kind of static
- 30:01Speaker 3: and they're also kind of artificial environment. So you know,
- 30:04Speaker 3: being able to be on the floor right now, In fact,
- 30:07Speaker 3: just in the last hour or half probably you've had
- 30:10Speaker 3: the opportunity to converse with you know, a half a
- 30:12Speaker 3: dozen pharmacists and the question is what what works for
- 30:17Speaker 3: the patient, what works for them, and then how that
- 30:19Speaker 3: translates all the way back through the you know, the
- 30:22Speaker 3: healthcare cycle with physicians and nurses. But you know, what
- 30:26Speaker 3: is really the best role for a topical pain page?
- 30:30Speaker 3: You know, when should they be using it? I would
- 30:32Speaker 3: rather hear directly from them who are hearing it directly
- 30:35Speaker 3: from their patients. So and that's what we see because
- 30:38Speaker 3: ultimately what we want is in our messaging and our
- 30:41Speaker 3: communication as an organization is what is going to resonate
- 30:46Speaker 3: because it has real value. It has it is translates
- 30:50Speaker 3: to what needs. Instead of us trying to be all
- 30:53Speaker 3: things to all people, or to try to force a
- 30:56Speaker 3: position because we think it sounds good, that's not that's
- 30:59Speaker 3: not our our job. Our job is to actually listen.
- 31:03Speaker 3: And if we listen well, then we can actually communicate
- 31:07Speaker 3: effectively and then hopefully the patient that can benefit from
- 31:10Speaker 3: our option will benefit and that's ultimately what we want
- 31:13Speaker 3: to do. If we can do that, I think we
- 31:15Speaker 3: could be successful in servicing the pain management community.
- 31:18Speaker 7: And that's where the win's at. You know, as a
- 31:20Speaker 7: pain and management person here, it's we've always got to
- 31:23Speaker 7: remember that. You know, we're all human, clinicians and everyone alike,
- 31:26Speaker 7: we're all human. We're all going to be in pain
- 31:28Speaker 7: sooner or later, and we're not gonna be in charge.
- 31:30Speaker 7: Then we're gonna be sitting on the gurney. We're gonna
- 31:32Speaker 7: be sitting on the stool waiting for someone else to
- 31:35Speaker 7: take care of us. And if these conversations at NCPA
- 31:39Speaker 7: with you find folks and everyone else don't happen, then
- 31:42Speaker 7: that person, that clinician is not going to be your
- 31:44Speaker 7: able take care of ourselves, going to take care of
- 31:46Speaker 7: all their patients and their communities alike. It's the biggest
- 31:51Speaker 7: thing that you just said that resonated with me was listening.
- 31:55Speaker 7: And I hope my wife's listening to the we all
- 31:59Speaker 7: you know, we could all all improve with listening sooner
- 32:01Speaker 7: or later here and there. But hearing from the folks
- 32:05Speaker 7: with the boots on the ground saying this is what
- 32:07Speaker 7: we're facing. Help me out when should I bring up
- 32:10Speaker 7: this conversation? When where do topicals fit in? You know,
- 32:13Speaker 7: earlier later and you know, typically talking prescription at that point,
- 32:18Speaker 7: they're certainly over the counter options as well too, but
- 32:20Speaker 7: fit finding the fit and the place. You know, I've
- 32:23Speaker 7: had wonderful opportunities in the past of working to make
- 32:26Speaker 7: you know, even our own state payments and guidelines, other guidelines,
- 32:30Speaker 7: other efforts, and it's like, where do these where all
- 32:32Speaker 7: the puzzle pieces fit well, they fit on the table.
- 32:36Speaker 7: As long as they're all there, we can decipher through one, two, three, four, five.
- 32:41Speaker 7: But as long as they're all there, someone knows about
- 32:43Speaker 7: all those options along the way, and that that's really,
- 32:47Speaker 7: you know, to what you were saying of listening to
- 32:49Speaker 7: everyone of what's the actual need? Yeah, whatever, you know
- 32:52Speaker 7: everyone walking around NCPA is saying is that's going to
- 32:55Speaker 7: translate to patient care pretty directly within a week.
- 32:58Speaker 3: So, given the professional that you are are in this
- 33:00Speaker 3: space and a leader in this space, I guess one
- 33:02Speaker 3: of the things would be where do you see topical
- 33:06Speaker 3: patches fitting on that table? For example, we had a
- 33:09Speaker 3: pharmacist come up to me today and we were talking
- 33:13Speaker 3: and they were kind of going through their mental gymnastis
- 33:17Speaker 3: of the patients that come in what fits well. And
- 33:20Speaker 3: one of the populations was the older population of Jerry
- 33:25Speaker 3: Unker population. So I would be really interested to continue
- 33:29Speaker 3: to build on that common in terms of with your
- 33:31Speaker 3: expertise and where do you see topicals being more appropriate
- 33:38Speaker 3: within the pain management? You know our toolbox if you will.
- 33:44Speaker 7: The toolbox open here. Yes, So I think it's it's
- 33:48Speaker 7: decently easy to speak on behalf of pharmacist the worldwide
- 33:52Speaker 7: there in that regard. You know, we worry about certain things,
- 33:56Speaker 7: how does it work when we're talking about a medication,
- 33:59Speaker 7: how does it work, the mechanism, how much for the dose?
- 34:03Speaker 7: And then what are those things resulting? Well, hopefully efficacy.
- 34:06Speaker 7: You want the darn thing to work, right, But we
- 34:09Speaker 7: all want our cake and eat it too. We want
- 34:10Speaker 7: it to work, but we also don't want side effects.
- 34:13Speaker 7: We want to avoid those pesky interactions there. Okay, that
- 34:17Speaker 7: ladder side there, if that was a timeline, that's where
- 34:20Speaker 7: it's at when it comes into play for top goals.
- 34:22Speaker 7: Now that's the whole population. Really. I'll get to the
- 34:24Speaker 7: geriatric part too. But you know, it's great if a
- 34:28Speaker 7: medication works, but if it also gives you five side effects,
- 34:32Speaker 7: well then is that really winning? Do you get the trophy?
- 34:35Speaker 7: I mean, you know, you help one thing couse five others.
- 34:38Speaker 7: That's a concern. I mean, even if it's just one
- 34:40Speaker 7: side effect. When you're talking at population like say long
- 34:43Speaker 7: term care geriatric patients sixty five and older, I mean,
- 34:47Speaker 7: in the big picture, everyone's either a geriatric patient or
- 34:51Speaker 7: wants to be one eventually, right, I hope to be I.
- 34:53Speaker 3: Mean yeah, we all hope to all the patient at
- 34:56Speaker 3: some point, right right.
- 34:57Speaker 7: It's so you know, guidelines that are out there. We
- 35:02Speaker 7: have the Beer's criteria to be ultra specific. I guess
- 35:05Speaker 7: they go into how do we best take care of
- 35:07Speaker 7: our geiatric patients and the multitude of all the recommendations
- 35:11Speaker 7: that charts. There's not that many, but there's a lot
- 35:13Speaker 7: of info in them. Is really about getting the job done,
- 35:17Speaker 7: efficacy and then safety side of avoiding the side effects.
- 35:20Speaker 7: So things that are sedating are things that could cause
- 35:24Speaker 7: a fall. That's big. Things could affect somebody's kidneys, you know,
- 35:28Speaker 7: all the bigger organs in a nutshell. Avoiding all that
- 35:32Speaker 7: is incredibly important. So it's really about picking the right medication,
- 35:36Speaker 7: the right dose, how does it work, how much to
- 35:39Speaker 7: ultimately get that efficacy and then avoid any safety concerns
- 35:42Speaker 7: along the way. Well, I mean in that timeline, you're
- 35:46Speaker 7: thinking about topicals, what's the point of a topical. Okay,
- 35:49Speaker 7: well it's not even transdermal, it's topical. Apply it here,
- 35:54Speaker 7: aiming for it to work right here and not go
- 35:56Speaker 7: all systemic on us, not go to the rest of
- 35:58Speaker 7: the body, not lead to side effects. Now topicals could
- 36:02Speaker 7: have side effects, things like the site reaction, so on
- 36:05Speaker 7: and so forth, but we're talking the systemic, the full body,
- 36:09Speaker 7: throughout the whole body side effects that you want to avoid,
- 36:12Speaker 7: and that's what happens all too often with oral medications
- 36:16Speaker 7: or in other formulations where topicals are right in the
- 36:19Speaker 7: middle of that equation of I want it to work
- 36:23Speaker 7: and I don't want any of the baggage with it.
- 36:25Speaker 3: So let me ask you a quick question before you
- 36:27Speaker 3: go on. So you make an interesting point. So, being
- 36:31Speaker 3: in the industry, I know the difference between a topical
- 36:33Speaker 3: and a transdermal patch. Do you think most patients or
- 36:37Speaker 3: even most pharmacists truly understand the difference between topical and
- 36:42Speaker 3: transdermal and then they know where and how they would
- 36:44Speaker 3: use them differently?
- 36:46Speaker 7: So no one, Yes, I think if I got the
- 36:48Speaker 7: order right there, I'm abundantly confident that any graduated licensed
- 36:53Speaker 7: pharmacist will know the difference between topical and transforming. I
- 36:57Speaker 7: would hope that even in almost any you know, we're
- 37:00Speaker 7: in the fall here now, so even a first euro
- 37:03Speaker 7: a PEE one student has had enough classes where I
- 37:05Speaker 7: would expect it, all of them, the divorce eudents at
- 37:07Speaker 7: least where they would know that that's the low hanging fruit.
- 37:10Speaker 7: Now a patient delay public, that's a whole another basket
- 37:14Speaker 7: of fruit there where you know you think fundamentally, where
- 37:18Speaker 7: you know pharmacists were medication experts, right, how do we
- 37:21Speaker 7: help a patient? Nine out of ten times it's with
- 37:24Speaker 7: the most basic information possible, like educating somebody that put
- 37:28Speaker 7: the patch there, it works elsewhere. That might sound like
- 37:32Speaker 7: magic to someone and they might be a very intelligent
- 37:36Speaker 7: human being. It's just different. It's not an intelligence thing.
- 37:40Speaker 7: It's an experience of hey, it makes common sense. But
- 37:42Speaker 7: the patch it probably works right there right well, transdermal
- 37:45Speaker 7: it's been to work elsewhere, it's going to actually be
- 37:46Speaker 7: absorbed more.
- 37:47Speaker 3: And the reason I as a question is learning right
- 37:49Speaker 3: when we're thinking about what we have to say, if
- 37:52Speaker 3: we're not doing a good job to make sure that
- 37:54Speaker 3: everybody understands the difference. Again, pharmacist was probably a rhetorical
- 37:58Speaker 3: question that they would know that, But you know, do
- 38:01Speaker 3: we have a responsibility as a company to make sure
- 38:03Speaker 3: that they understand the difference between a topical and a
- 38:07Speaker 3: transdermal patch. Maybe that's something that we should be thinking
- 38:10Speaker 3: about too, just to make sure that we're doing everything
- 38:13Speaker 3: we can to make sure one, most importantly, we stay
- 38:15Speaker 3: within label and two that we continue to make sure
- 38:19Speaker 3: they're educated at a level so that when a choice
- 38:22Speaker 3: is made, especially when they go home, because once they
- 38:25Speaker 3: leave a physician or pharmacist, they are home with these products.
- 38:28Speaker 3: So do they go home and then realize, well, I
- 38:30Speaker 3: put it on, is it working away? I think is
- 38:32Speaker 3: supposed to work versus the way it should be working,
- 38:34Speaker 3: and they would be able to connect the two. So again,
- 38:37Speaker 3: I think ultimately we always wanted to deliver our messaging
- 38:40Speaker 3: through the healthcare provider because you guys are the experts.
- 38:44Speaker 3: You guys are the ones that are certified to do
- 38:46Speaker 3: it and have gone and gotten the degrees to do it.
- 38:48Speaker 3: We don't. But so that's the really.
- 38:50Speaker 7: Reason why I was likeyings, Tim, Yeah, to your point
- 38:53Speaker 7: of you know what is what's that responsibility to clinicians,
- 38:56Speaker 7: to healthcare professionals were in those reminders out there, because
- 39:00Speaker 7: you know, when a patient walks into a pharmacy, that's
- 39:03Speaker 7: a that's a moment for them, It's one of five
- 39:06Speaker 7: hundred moments for the actual pharmacist. And just remembering in
- 39:10Speaker 7: that moment that the for instance, I had a patient
- 39:13Speaker 7: come into a pharmacist I was managing once and their
- 39:16Speaker 7: question I thought was pretty straightforward. They were like, can
- 39:19Speaker 7: you help me find the tilin all? I mean, absolutely,
- 39:24Speaker 7: let's get this done. And I personally went out and
- 39:27Speaker 7: then once we got in the aisle, I realized I
- 39:29Speaker 7: didn't understand the question. I didn't. I mean, there wasn't
- 39:33Speaker 7: much to listen to, but I didn't listen. She wanted
- 39:35Speaker 7: to know where the regular strength was three twenty five
- 39:37Speaker 7: and the whole aisle of seven hundred and seventy five
- 39:40Speaker 7: boxes was five hundred milligrams. And I tell you what,
- 39:43Speaker 7: it took me three minutes, hold your breath for three minutes.
- 39:45Speaker 7: That kind of three minutes to find that product for her. Now,
- 39:50Speaker 7: that's that's a little bit more mundane than topical versus transgerma.
- 39:53Speaker 7: That's why I would, you know, would be on board
- 39:55Speaker 7: with that whole getting reminders out there of what someone
- 39:57Speaker 7: could be asking listening even when you listen, and you
- 40:01Speaker 7: might need some warningful there too. After listening, figuring out
- 40:03Speaker 7: what to ask next, like asking that patiently, okay, when
- 40:07Speaker 7: you say I don't i'll see the benefit paracetamol to the
- 40:10Speaker 7: rest of the world. What do you mean, what are
- 40:12Speaker 7: you actually looking for? And then in that case, it
- 40:15Speaker 7: was the oh I don't want that extra trend. That's
- 40:16Speaker 7: that's too powerful in that perspective, and it was like, oh, wow,
- 40:19Speaker 7: this is actually a really good question. I feel bad
- 40:22Speaker 7: for the rest of my staff they don't get to
- 40:23Speaker 7: help now, so that you know, that's even a little
- 40:26Speaker 7: different than topic versus transferable. But there's a little reminders
- 40:29Speaker 7: because those are special moments when patients are coming in.
- 40:32Speaker 3: Yeah. So again I guess back, maybe because I interrupted
- 40:35Speaker 3: you with that other thought, it was that you know
- 40:36Speaker 3: that the patients and we were talking about the geriatric
- 40:40Speaker 3: patient as an example, or I don't know, you know
- 40:45Speaker 3: people using it for athletics things like that. So I
- 40:48Speaker 3: guess the really question is from your expertise, you know,
- 40:53Speaker 3: where are the areas in those kind of subpot patient
- 40:57Speaker 3: populations that you that you think of the write ones
- 41:00Speaker 3: for a topic your package, so.
- 41:03Speaker 7: You know, big picture again, top goal is an option
- 41:06Speaker 7: for just about anyone. I don't want to go on
- 41:09Speaker 7: the record. You're like, oh, absolutely everybody, And then you
- 41:11Speaker 7: know my colleagues will find some reason not to as
- 41:14Speaker 7: But there's different snares. Geriatric pation is certainly one large
- 41:18Speaker 7: population that it will fit in. But you take any
- 41:21Speaker 7: other get rid of the age part. What about other
- 41:24Speaker 7: medications that's so on, you know right right, other conditions, comorbidities,
- 41:30Speaker 7: other medications that someone's on. You know, you could be
- 41:34Speaker 7: a young patient or or you know, newly minted adult
- 41:38Speaker 7: in college, even on multiple medications, and if you add
- 41:41Speaker 7: a certain pain medicine OTC or prescription, there may be
- 41:44Speaker 7: an interaction there or side effects that could be very concerning,
- 41:49Speaker 7: you know, blood thinning for instance, or maybe they're having
- 41:52Speaker 7: procedures done. And then it's not going to be every
- 41:54Speaker 7: day that it's a concern, but in that day where
- 41:56Speaker 7: it's a concern, it's a big day.
- 41:58Speaker 3: It only takes one day, yep.
- 42:01Speaker 7: What one bad day can give us all right, But
- 42:04Speaker 7: those are things that we all have to take into
- 42:06Speaker 7: account that pharmacists to day in and day out, boots
- 42:09Speaker 7: on the ground for patient care, right there on the
- 42:12Speaker 7: front lines. But it's not just specific populations even it's
- 42:16Speaker 7: it's any person once knowing their their information. You know,
- 42:20Speaker 7: you mentioned you'll lived at too earlier of the you know,
- 42:22Speaker 7: as pharmacists, we don't always get all the information those
- 42:25Speaker 7: are that those situations are improving these days, but we're
- 42:29Speaker 7: nowhere near where we need to. You know, it's not
- 42:31Speaker 7: like electronic healthcare records are accessible by every community pharmacy
- 42:34Speaker 7: in the country. We don't operate on the same cloud.
- 42:38Speaker 7: There's all that you know stuff of opportunities, but you know,
- 42:41Speaker 7: conversations and learning about a patient and what they have
- 42:43Speaker 7: going on. There's some basics there too. There are still
- 42:46Speaker 7: good opportunities.
- 42:47Speaker 3: So Mark, you know, obviously I'm not an expert in pain.
- 42:52Speaker 3: We obviously saw you know, frogs for pain at you out,
- 42:55Speaker 3: but you've been around this and obviously have put yourself
- 42:58Speaker 3: to be a leader in pain education, knowledge and training.
- 43:02Speaker 3: So what we what do we need to do additional
- 43:07Speaker 3: as a company outside the product to help because obviously
- 43:12Speaker 3: you're writing guidelines and you've led the guidelines in your
- 43:15Speaker 3: own state, and we know there is obviously the pressure
- 43:20Speaker 3: throughout the system in terms of how do we manage oipoids? Ooh,
- 43:25Speaker 3: you said the word I did, but not so much
- 43:27Speaker 3: about the oil bits. But my question is really more
- 43:30Speaker 3: about things are evolving. I guess maybe that's what's going
- 43:34Speaker 3: right because of the history, because of where we are,
- 43:37Speaker 3: we are changing how we look at it. And to
- 43:39Speaker 3: your point, it's always about the right, having the choices
- 43:42Speaker 3: and using right. What else can we do? Is there
- 43:44Speaker 3: anything else we could do that help pharmacists besides outside
- 43:48Speaker 3: of the product, I mean, is there enough communication out
- 43:53Speaker 3: there now where they're getting, all the pharmacists are getting
- 43:55Speaker 3: the education. I would just like to look beyond just
- 43:59Speaker 3: the product, because at your RAU we try to be
- 44:02Speaker 3: more than just a selling product. I mean, I always
- 44:05Speaker 3: believe if we do what's right, the product will take
- 44:07Speaker 3: care of itself. So I know I'm going a little
- 44:09Speaker 3: off tangent on something specific, but I you know, that's
- 44:12Speaker 3: why we're here is to learn and to listen. So
- 44:15Speaker 3: I would really be interested to see if you felt
- 44:18Speaker 3: that you guys have the resources and tools and what
- 44:21Speaker 3: else does the manufacturer could possibly bring to the equation
- 44:24Speaker 3: to help in that process.
- 44:26Speaker 7: The awareness is a big thing, you know, merely being
- 44:30Speaker 7: in a conference. There's not that many manufacturers at conferences
- 44:33Speaker 7: these days, at least across the board, but that presence,
- 44:37Speaker 7: you know, everyone that walked by, there's a large percentage
- 44:40Speaker 7: that they're going to think, hey, there's some options there now,
- 44:43Speaker 7: and then later on this week we're going to be
- 44:46Speaker 7: giving patient care in their pharmacies everywhere, and then it's
- 44:49Speaker 7: going to be a little bit more, a little easier
- 44:51Speaker 7: to recollect what some options are for a given patient,
- 44:54Speaker 7: pay me in to then have that pharmacist or that
- 44:57Speaker 7: pharmacy team, you know, collaborating with local clinics, local prescribers,
- 45:01Speaker 7: so on and so forth to make it happen for
- 45:03Speaker 7: that patient. Because when it hits the fan and somebody's
- 45:06Speaker 7: in pain, where are they going? They're going to the
- 45:09Speaker 7: closest option, and that's us pharmacists. Whether it's a phone,
- 45:13Speaker 7: whether it's in person, that's where someone's going. Anywhere else
- 45:18Speaker 7: is so much red tape that it's actually like a
- 45:21Speaker 7: road paved of red tape. It is so hard to
- 45:24Speaker 7: navigate our healthcare system today with the sole exception of
- 45:27Speaker 7: walk into a pharmacy, asked some questions to have a
- 45:29Speaker 7: great conversation. So the presence that you and others are
- 45:33Speaker 7: doing is really helping with that pretty directly, most would
- 45:36Speaker 7: say in directly, but helping with that. Education is out there.
- 45:40Speaker 7: There's a lot of options for pay management education. A
- 45:44Speaker 7: lot of US pharmacists are involved in a lot of
- 45:46Speaker 7: those to get those messages out there, but in a professionally,
- 45:49Speaker 7: a lot of prescribers of all types, mid level along
- 45:53Speaker 7: the way, everyone's involved in those. So there's education out there,
- 45:57Speaker 7: but it's really just more of those touch points, you know,
- 46:00Speaker 7: having those moments of you know, talking with you know
- 46:03Speaker 7: here at NCPA twenty twenty four, you know, talking with
- 46:06Speaker 7: pharmacy owners, pharmacy teams, raising that awareness overall, the you know,
- 46:12Speaker 7: the listening, the taking action, that responsibility to the community.
- 46:17Speaker 7: For a manufacturer, just like with a community pharmacy, having
- 46:21Speaker 7: that responsibility to raise awareness overall and get it done,
- 46:25Speaker 7: for adding options into people's you know, to recollect being
- 46:29Speaker 7: able to pull up that information.
- 46:30Speaker 3: Well, you know, maybe we'll divert a little bit more
- 46:32Speaker 3: off of pain specifically, because another thing that he says
- 46:35Speaker 3: really important, and I think it's a basis of why
- 46:40Speaker 3: we hear on the Pharmacy Network podcast is the commitment
- 46:43Speaker 3: to the pharmacist. And one of the things that we're
- 46:46Speaker 3: trying to navigate too is manufacturers because there's a lot
- 46:48Speaker 3: of changes in the pharmacy right We just saw an
- 46:51Speaker 3: announcement I think was it last week or the week
- 46:53Speaker 3: before that Walgreens is going to shut down twelve hundred
- 46:57Speaker 3: stores in the course of the next two years. I
- 46:59Speaker 3: think it was the time frame. We know there's about
- 47:02Speaker 3: just over twenty thousand. I think independent pharmacy and pharmacy
- 47:05Speaker 3: is still actively operating, and with all these changes, I
- 47:10Speaker 3: think the independent pharmacist is going to become even more important,
- 47:13Speaker 3: not less important. But it's still scary because the way
- 47:17Speaker 3: the dynamics work in pharmacy, it's not an easy business.
- 47:21Speaker 3: It's almost a labor of love as much as anything now,
- 47:24Speaker 3: like a lot of things, because they don't get reimbursed
- 47:26Speaker 3: at the level they should be. Many products that they
- 47:30Speaker 3: dispense to their patients they get rebursed at a lower
- 47:33Speaker 3: rate than what they're dispensing cost is their raw cost
- 47:37Speaker 3: and dispens prescription. So what else do we need to
- 47:41Speaker 3: think about the dynamic change in pharmacy as a manufacturer
- 47:45Speaker 3: to help because obviously the big retail dynamics changing the
- 47:49Speaker 3: internet based pharmacies are there, but I don't think they've
- 47:52Speaker 3: really gone as big as I thought. Maybe originally everybody
- 47:57Speaker 3: would convert over so all of a sudden, this independent
- 47:59Speaker 3: farm is still there and strong. How do we continue
- 48:02Speaker 3: to as a manufacturer to support them? Any ideas?
- 48:05Speaker 7: That is a phenomenal, huge question that it probably should
- 48:08Speaker 7: be on a presidential debate. Good gully, But I'll try,
- 48:12Speaker 7: I'll try.
- 48:12Speaker 3: Please do it.
- 48:13Speaker 7: The disease absolutely, the you know, community pharmacy has always
- 48:18Speaker 7: been there. When if you talk to anyone someone who's
- 48:21Speaker 7: eventually going to be a pharmacist of fifty years of
- 48:23Speaker 7: a career. Originally, when asked what does a pharmacist do,
- 48:27Speaker 7: you're going to be thinking about a community pharmacist. That
- 48:30Speaker 7: pharmacist might be ending up working for the FDA, the
- 48:32Speaker 7: hero of public health, the management organization, a manufacturer, you
- 48:37Speaker 7: name it. But it all starts back with a community
- 48:40Speaker 7: pharmacy setting. It's the fundamental part of it all. Always
- 48:45Speaker 7: been there, always will be. Yes, there's some fog in
- 48:48Speaker 7: the air these days, even at the corporate compared to
- 48:52Speaker 7: independent pharmacy level, the dynamics are changing, yess. But in
- 48:56Speaker 7: the end, people need pharmacists, not just the product, but
- 49:01Speaker 7: they need cognitive services. They need if you want to
- 49:05Speaker 7: call it, physical services, things like umunization, you name it.
- 49:08Speaker 7: All of those services are needed, and so many independent
- 49:11Speaker 7: pharmacies are adapting to that. There's actually a wonderful story
- 49:16Speaker 7: lost in the shuffle of how they're rising as the
- 49:19Speaker 7: cream of the crop to come to the rescue of
- 49:21Speaker 7: what's needed for our communities. Now that's a glass half full.
- 49:25Speaker 7: Everything I just said in the last forty five seconds,
- 49:27Speaker 7: don't get me wrong, but that's the story when we
- 49:30Speaker 7: look back in twenty years, that's the story. We're always
- 49:32Speaker 7: been there, always will be, and the patient's right in
- 49:35Speaker 7: the middle there. And it's incredibly important to remember that
- 49:39Speaker 7: because again, where are patients going to go? Well, we're everywhere,
- 49:43Speaker 7: so that's where we're going to go.
- 49:45Speaker 3: You know, that's a real actually wow moment, light bulb
- 49:48Speaker 3: above my head kind of comment. I'm being very serious
- 49:51Speaker 3: here because you know, what you said is struck was
- 49:54Speaker 3: so important to us, is that an independent pharmacy background
- 49:59Speaker 3: is probably more relevant in terms of proliferation of pharmacists
- 50:04Speaker 3: into the system, whether it be governmental or other than
- 50:07Speaker 3: probably maybe somebody just working for our big chain retail. So,
- 50:12Speaker 3: you know, it just it just actually got me more
- 50:15Speaker 3: excited on the efforts that we're putting an independent pharmacy
- 50:18Speaker 3: because these are the people that are ultimately going to
- 50:20Speaker 3: be changing behavior, changing policy, or influencing it in ways
- 50:26Speaker 3: more so than many others. So that's that's pretty exciting
- 50:30Speaker 3: stuff because it is and it's.
- 50:32Speaker 7: Even been you know, relatively recently. You know, you look
- 50:35Speaker 7: back to COVID times, you know, even early COVID times,
- 50:39Speaker 7: where on this planet were the leaders for you know,
- 50:43Speaker 7: once the COVID vaccination and everybody's got opinions, and there's
- 50:46Speaker 7: twenty sides to every coin. But in the nuts and
- 50:49Speaker 7: bolts of it, for the distribution of that vaccine, where
- 50:52Speaker 7: were the leaders for our globe and for day proud
- 50:56Speaker 7: to say, actually in wild and wonderful West Virginia. But
- 50:58Speaker 7: it was pharmacy. And the way that that worked was
- 51:01Speaker 7: because everybody bucked the system. Disclaimer by the way, I'm
- 51:04Speaker 7: not a pharmacy owner. I never have been in the future.
- 51:08Speaker 7: Who knows, right, But like these are the folks, my friends,
- 51:12Speaker 7: Mike colleagues in the general area where community pharmacists, independent pharmacists,
- 51:17Speaker 7: interstate stepped up like no one on the planet and
- 51:20Speaker 7: got it done. And then we're featured internationally. And that's
- 51:23Speaker 7: in an environment where when you look at health statistics,
- 51:25Speaker 7: we're literally at the bottom of everything. Yeah, so it's
- 51:29Speaker 7: you know, when it's the darkest, there's still things that
- 51:31Speaker 7: come through on the apses.
- 51:33Speaker 3: Well, you convinced me more as the CEO of the company,
- 51:36Speaker 3: that our investment in the pharmacy channel and specifically independent
- 51:41Speaker 3: pharmacy and we need to continue to do that. It's
- 51:45Speaker 3: easy to do the things we've always done. And don't
- 51:48Speaker 3: get me wrong, physicians are very important. They ultimately prescribe
- 51:51Speaker 3: product for the patient, and they're obviously a big part
- 51:54Speaker 3: along with the pas and nurses and so forth. But ultimately,
- 51:59Speaker 3: for a company like us, the pharmacist represents the healthcare
- 52:04Speaker 3: providers really going to be a facilitator of questioning good choice,
- 52:12Speaker 3: is it the right thing? Raising options, and again in
- 52:16Speaker 3: pain management, as we bring it back to pain management,
- 52:19Speaker 3: if options are key, then we have to make sure
- 52:22Speaker 3: that we educate the pharmacists in order to help them
- 52:26Speaker 3: be the best they can be at articulating that to
- 52:29Speaker 3: the patients and also collaborating with the positions as they're
- 52:32Speaker 3: prescribing those diplomatications. So I don't know what else we
- 52:37Speaker 3: really need to cover today outside of the fact that
- 52:40Speaker 3: maybe conclude again with any other thoughts you have on
- 52:44Speaker 3: topical patches and the role they play. But be rest
- 52:48Speaker 3: assured that you know at Urral we have too. We
- 52:51Speaker 3: have light of Kin five percent patch and we have
- 52:53Speaker 3: the Clofin at one point three patch, and we believe
- 52:56Speaker 3: in these products and we believe they are high quality
- 52:58Speaker 3: and we believe they do exactly what you said. They're
- 53:00Speaker 3: there for a purpose, for the right patient at the
- 53:03Speaker 3: right time. So as long as we can continue to
- 53:06Speaker 3: learn about what the right patient is and what the
- 53:09Speaker 3: right time is, and hopefully that we will continue to
- 53:12Speaker 3: do our part to promote, promote ethically and appropriately and
- 53:17Speaker 3: continue to share the awareness and information so that people
- 53:20Speaker 3: that are in charge to make those decisions on behalf
- 53:22Speaker 3: of those patients will make the best decisions across the board.
- 53:25Speaker 3: But any other thoughts.
- 53:26Speaker 7: That you have, absolutely the you know, I'd want to
- 53:29Speaker 7: go to the interprofessional side. I think my glass was
- 53:32Speaker 7: completely full of pharmacy for this conversation. But you know,
- 53:36Speaker 7: in an interprofessional sense, this is an incredibly important topic.
- 53:41Speaker 7: The you know, when whether someone's a prescriber, a dispenser,
- 53:45Speaker 7: you name the title, the type of clinician, the type
- 53:47Speaker 7: of healthcare professional, we all work together. There is a
- 53:51Speaker 7: much more inter professional vibe in healthcare now compared to
- 53:56Speaker 7: decades ago, even when I wasn't even around. Maybe not,
- 53:59Speaker 7: but it's incredibly important to to take a look at
- 54:03Speaker 7: you know, what what are you know you mentioned some
- 54:05Speaker 7: indications there of like okay, well, you know, someone in
- 54:09Speaker 7: a in a prescribing sense, a diagnostician is going to
- 54:13Speaker 7: be a Jedi master at diagnosis. That's what they do.
- 54:18Speaker 7: And that's not getting to the medications just yet. But
- 54:20Speaker 7: you know, when you look at indications like sprain and strain,
- 54:24Speaker 7: go ask one hundred people right now the difference and
- 54:26Speaker 7: you'll get about one hundred and twenty different answers. And
- 54:31Speaker 7: unless there I don't know if the option is I
- 54:33Speaker 7: don't know, that'll be out there too. Like sprain, it
- 54:36Speaker 7: involves you know, like amn's it's bone to strain with
- 54:39Speaker 7: the t in there that that's more the tendon that's
- 54:42Speaker 7: muscles or muscles to bone. The former has the bruising,
- 54:47Speaker 7: the latter typically doesn't. But we're human, we're wild, we're wicked,
- 54:50Speaker 7: we're awesome, we might those types of things. You know
- 54:54Speaker 7: that that you know when you're looking at SA you know,
- 54:57Speaker 7: MDDO advanced practic listeners, practitioners, physicians, assistants. That's that's in
- 55:03Speaker 7: the realm there, and then pharmacy in that same realm
- 55:06Speaker 7: working through here's our options. We now know what's going on,
- 55:10Speaker 7: what are the options, let's work together with that. It's
- 55:13Speaker 7: incredibly important for that and community pharmacy oftentimes you know,
- 55:17Speaker 7: gets that kind of the kidney punch of like, well,
- 55:19Speaker 7: we don't have the info. We're over on the own,
- 55:21Speaker 7: our own island there, speaking from my own experience, but
- 55:24Speaker 7: it's not that. It's you know, that communication in the background,
- 55:27Speaker 7: and it's tough these days, but we do have technology
- 55:30Speaker 7: of making that happen of you know, hey this, you
- 55:33Speaker 7: know X y Z was prescribed, did we try a
- 55:36Speaker 7: B and C first? That would behoove to patient. It's
- 55:41Speaker 7: really important in that inter professional sense in the big
- 55:43Speaker 7: picture pharmacy certainly having a pretty darn good seat at
- 55:47Speaker 7: that date over all these days.
- 55:49Speaker 3: Yeah, well, again a great point at the end of
- 55:52Speaker 3: day that the interdependency in our industry, on the drug
- 55:56Speaker 3: side or on the healthcare delivery side, there is a
- 55:59Speaker 3: tremendous amount of independency, and I think people that are
- 56:01Speaker 3: willing to take the time to really think through those
- 56:04Speaker 3: independencies will ultimately have the ability to deliver a better outcome.
- 56:09Speaker 3: And that's what we do. You know, I'm not a physician,
- 56:12Speaker 3: I'm not a pharmacist, but I got in this industry
- 56:15Speaker 3: when I came out of undergrad and I had seven
- 56:18Speaker 3: job offers opportunities. One was with Coca Cola, one was
- 56:22Speaker 3: a company called Armstrong World Industry that sold flooring and
- 56:25Speaker 3: two pharmaceutical opportunities, one and with a newspaper because I
- 56:29Speaker 3: put myself through school working at the local newspaper. And
- 56:33Speaker 3: I was interesting because I up at that point I
- 56:36Speaker 3: didn't do healthcare. You know, I wasn't a biology major
- 56:39Speaker 3: or something. I was a business major. And one of
- 56:42Speaker 3: the companies said, well, we're looking for good people that
- 56:44Speaker 3: can help articulate the value of what we do, not
- 56:47Speaker 3: that you know every thing and either you'll do it
- 56:49Speaker 3: well you won't. But when I had to make a choice,
- 56:52Speaker 3: it came down pretty easiest. I could sell syrup, I
- 56:55Speaker 3: could sell flooring, not that those industries are bad for
- 56:58Speaker 3: anybody out there, because I do like a good floor
- 57:00Speaker 3: and I've been known to have a coke on occasion,
- 57:03Speaker 3: but you know, the opportunity to impact health outcome of
- 57:08Speaker 3: patients became a no brainer. And I've been in it
- 57:10Speaker 3: for over thirty plus years, so I guess it was
- 57:13Speaker 3: the right fit at the end of the day, So
- 57:15Speaker 3: I guess really. First of all, Mark, thank you for
- 57:19Speaker 3: being here and thank you for what you do. It
- 57:21Speaker 3: takes strong, courageous people to step up and be leaders
- 57:25Speaker 3: in what they do, and the fact that you have
- 57:27Speaker 3: established yourself as a leader in a very very important
- 57:30Speaker 3: area in terms of pain management says a lot about
- 57:33Speaker 3: you and your commitment to patients. So thank you and
- 57:35Speaker 3: hopefully your RAL ultimately over time will continue to be
- 57:38Speaker 3: see as an organization that will do the same. So
- 57:42Speaker 3: thank you so much. It was a great conversation.
- 57:44Speaker 7: You're welcome. And I've got one one last bit of
- 57:47Speaker 7: news for you, Steven. You were destined to be with
- 57:49Speaker 7: pharmacy because when you had the Coca Cola, often turns
- 57:53Speaker 7: out the guy that made that and the six pack
- 57:55Speaker 7: was a pharmacist.
- 57:56Speaker 3: Oh there you go, and that's right, you know. And
- 57:57Speaker 3: I guess we should say something about the Farmacy Podcast
- 58:01Speaker 3: Network Pharmacy Podcast Network. I'll say that, well, because Todd
- 58:06Speaker 3: and his team and do an amazing job. I've created
- 58:09Speaker 3: a platform I think now exceeds over one hundred thousand
- 58:13Speaker 3: pharmacists as subscribed, and this is becoming such an enriched
- 58:19Speaker 3: platform and becoming basically the go to platform for pharmacists.
- 58:24Speaker 3: I haven't actually told Todd this, but I actually have
- 58:27Speaker 3: haden three calls from people that have listened to the
- 58:29Speaker 3: podcast the past podcast we've done wanting to know more
- 58:33Speaker 3: about how we as an organization are working to help
- 58:36Speaker 3: work with them, and so it works and you guys
- 58:39Speaker 3: are and he's tackling a lot of topics obviously beyond pain,
- 58:43Speaker 3: and we are glad to be a part of their
- 58:46Speaker 3: effort and we look forward to being part of it
- 58:48Speaker 3: for a long time to go.
- 58:59Speaker 10: We both syrox and sodium capsules are al thyroxine t
- 59:02Speaker 10: for indicated for use in adults and pediatric patients six
- 59:05Speaker 10: years and older with hypothyroidism. Levothyroxin sodium capsules can also
- 59:10Speaker 10: be used for pituitary thyrotrophin suppression.
- 59:12Speaker 1: Thyroid hormones, including levothyroxin sodium capsules should not be used
- 59:17Speaker 1: for the treatment of obesity or for weight loss. Doses
- 59:20Speaker 1: beyond the range of daily hormonal requirements may produce serious
- 59:23Speaker 1: or even life threatening manifestations of toxicity.
- 59:26Speaker 10: Levothyroxin sodium capsules are not indicated for suppression of benign
- 59:30Speaker 10: thyroid nodules and non toxic diffuse goiter in iodine sufficient patients,
- 59:34Speaker 10: or for the treatment of transient hypothyroidism during the recovery
- 59:38Speaker 10: phase of subacute thyroiditis.
- 59:40Speaker 1: Levothyroxin sodium capsules are contraindicated in patients with uncorrected adrenal insufficiency.
- 59:46Speaker 1: For elderly patients and those with underlying cardiovascular conditions, starting
- 59:50Speaker 1: with a lower dose is recommended due to the heightened
- 59:52Speaker 1: risk of cardiac adverse reactions, including atrial fibrillation.
- 59:56Speaker 10: Oral thyroid hormone drugs should not be used to treat
- 59:59Speaker 10: mixeddemic coma, and replacement glucocorticoids are necessary for patients with
- 1:00:03Speaker 10: concomitant adrenal insufficiency. Before initiating levothyroxin sodium capsules to prevent hyperthyroidism,
- 1:00:09Speaker 10: or for the incomplete treatment of hypothyroidism, Proper dose titration
- 1:00:13Speaker 10: and careful monitoring are essential. Diabetic patients should carefully monitor
- 1:00:17Speaker 10: glycemic control after starting, changing, or discontinuing thyroid hormone therapy,
- 1:00:22Speaker 10: since glycemic control may worsen.
- 1:00:24Speaker 1: In diabetic patients, decreased bone mineral density associated with thyroid
- 1:00:28Speaker 1: hormone over replacement may occur.
- 1:00:30Speaker 10: Adverse reactions associated with levothyroxin sodium capsules primarily reflect symptoms
- 1:00:35Speaker 10: of hyperthyroidism due to overdosage, including arrhythmias, heart attack, dyspmia,
- 1:00:40Speaker 10: muscle spasm, headache, nervousness, irritability, insomnia, tremors, muscle weakness, increased appetite,
- 1:00:47Speaker 10: weight loss, diarrhea, heat intolerance, menstrual irregularities, and skin rash.
- 1:00:53Speaker 10: Patients should ask their doctor if levothyroxin sodium capsules are
- 1:00:56Speaker 10: right for them. For more information and full prescribing information,
- 1:01:00Speaker 10: including boxed warning and important safety information, visit www dot
- 1:01:04Speaker 10: urlpharma dot com